These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18708356)

  • 41. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b.
    Hofmann H; Flöss S; Stamminger T
    J Virol; 2000 Mar; 74(6):2510-24. PubMed ID: 10684265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein.
    Dorval V; Fraser PE
    J Biol Chem; 2006 Apr; 281(15):9919-24. PubMed ID: 16464864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein modification by SUMO.
    Johnson ES
    Annu Rev Biochem; 2004; 73():355-82. PubMed ID: 15189146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies.
    Lehembre F; Badenhorst P; Müller S; Travers A; Schweisguth F; Dejean A
    Mol Cell Biol; 2000 Feb; 20(3):1072-82. PubMed ID: 10629064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sumoylation modulates the assembly and activity of the pre-mRNA 3' processing complex.
    Vethantham V; Rao N; Manley JL
    Mol Cell Biol; 2007 Dec; 27(24):8848-58. PubMed ID: 17923699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C-terminal Region and SUMOylation of Cockayne Syndrome Group B Protein Play Critical Roles in Transcription-coupled Nucleotide Excision Repair.
    Sin Y; Tanaka K; Saijo M
    J Biol Chem; 2016 Jan; 291(3):1387-97. PubMed ID: 26620705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.
    Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA
    Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SUMO-1 modification increases human SOD1 stability and aggregation.
    Fei E; Jia N; Yan M; Ying Z; Sun Q; Wang H; Zhang T; Ma X; Ding H; Yao X; Shi Y; Wang G
    Biochem Biophys Res Commun; 2006 Aug; 347(2):406-12. PubMed ID: 16828461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
    Saitoh H; Hinchey J
    J Biol Chem; 2000 Mar; 275(9):6252-8. PubMed ID: 10692421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization and mutational analysis of the RecQ core of the bloom syndrome protein.
    Janscak P; Garcia PL; Hamburger F; Makuta Y; Shiraishi K; Imai Y; Ikeda H; Bickle TA
    J Mol Biol; 2003 Jun; 330(1):29-42. PubMed ID: 12818200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
    Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
    Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SUMO assay with peptide arrays on solid support: insights into SUMO target sites.
    Schwamborn K; Knipscheer P; van Dijk E; van Dijk WJ; Sixma TK; Meloen RH; Langedijk JP
    J Biochem; 2008 Jul; 144(1):39-49. PubMed ID: 18344540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing.
    Martin SF; Hattersley N; Samuel ID; Hay RT; Tatham MH
    Anal Biochem; 2007 Apr; 363(1):83-90. PubMed ID: 17288980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of DNA binding by differential sumoylation of heat shock factors.
    Anckar J; Hietakangas V; Denessiouk K; Thiele DJ; Johnson MS; Sistonen L
    Mol Cell Biol; 2006 Feb; 26(3):955-64. PubMed ID: 16428449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.
    Hughes DJ; Tiede C; Penswick N; Tang AA; Trinh CH; Mandal U; Zajac KZ; Gaule T; Howell G; Edwards TA; Duan J; Feyfant E; McPherson MJ; Tomlinson DC; Whitehouse A
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assays of SUMO protease/isopeptidase activity and function in mammalian cells and tissues.
    Kunz K; Müller S; Mendler L
    Methods Enzymol; 2019; 618():389-410. PubMed ID: 30850061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteins with two SUMO-like domains in chromatin-associated complexes: the RENi (Rad60-Esc2-NIP45) family.
    Novatchkova M; Bachmair A; Eisenhaber B; Eisenhaber F
    BMC Bioinformatics; 2005 Feb; 6():22. PubMed ID: 15698469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides.
    Hsiao HH; Meulmeester E; Frank BT; Melchior F; Urlaub H
    Mol Cell Proteomics; 2009 Dec; 8(12):2664-75. PubMed ID: 19721078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.
    Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC
    J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.